On September 2, 2014, shares in Exelixis, a drug maker that has spent two decades trying to turn the early fruits of genetic research into drugs, plunged 48% as it announced that its cancer drug, Cometriq, did not extend survival in patients with advanced prostate cancer that had spread to [...]
Bristol-Myers Squibb Co (NYSE:BMY) has announced an exclusive agreement with BAVARIAN NORDIC (OTCMKTS:BVNRY) over the Danish-based company’s prostate cancer drug Prostvac, which is currently undergoing clinical trials. The deal could be worth up to almost $1 billion if the clinical trials yield positive results.
Men who have a vasectomy face an increased chance of developing prostate cancer and a higher risk of contracting the most aggressive form of the disease, a study has found.
The Harvard research on 50,000 men, the largest study to examine the link between sterilization and cancer, found that those who had the procedure had a 10% greater chance of developing the disease.
It also found a sharp increase in the risk of contracting the most aggressive form of prostate cancer, although this type of the disease is still relatively rare.
In October 2012 I was diagnosed with prostate cancer. I am now cancer free. Here is my story, a detailed one, with test results.I have been taking PSA tests every couple years since 2007. It's a routine blood test recommended for men as they get older.PSA stands for Prostate Specific Antigen. Elevated readings may indicate evidence of prostate cancer. Any reading under 3.0 is normal but some doctors may say 4.0 and others 2.5. It's not an exact science to be sure.
A saliva test to reveal a patient's risk of breast or prostate cancer could be available in doctors' surgeries within five years, according to a "groundbreaking" study. A major research drive involving more than 1,000 experts has revealed more than 80 genes which help determine from birth whether or not someone will develop cancer during their life.
A new Canadian study suggests some men are likely to die needlessly because of expert reports that discouraged use of a common test for prostate cancer, says a leading urologist, adding fuel to a heated debate around mass cancer screening.
The number of men who had biopsies and were diagnosed with both low-grade and high-grade prostate tumours at a Toronto network of hospitals dropped sharply after an American report recommended against so-called PSA screening, the study found.